Citric acid strongly inhibits visceral pain response in mice by Abdel-Salam, Omar M. E. & Baiuomy, Ayman R.
EXCLI Journal 2008;7:93-103 – ISSN 1611-2156 
Received: March 17, 2008, accepted: April 16, 2008, published: April 17, 2008 
 
93 
Original article: 
CITRIC ACID STRONGLY INHIBITS VISCERAL PAIN RESPONSE 
IN MICE 
Omar M.E. Abdel-Salam*, Ayman R. Baiuomy 
 
Department of Pharmacology, National Research Centre, Cairo, Egypt 
*Correspondence: Omar M.E. Abdel Salam (MD, PhD), Department of Pharmacology, Na-
tional Research Centre, Tahrir St., Cairo, Egypt. FAX: 3370931 
E-mail: omasalam@hotmail.com 
 
ABSTRACT 
 
Citric acid introduced into the stomach of mice at increasing concentrations of 0.1, 1 or 10 % 
(4.8 μM-0.48 mM; 95 μmol/kg–9.5 mmol/kg, 0.5 ml) caused dose-dependent inhibition of 
abdominal constrictions induced 1 h later by i. p. acetic acid injection by –51 % to -69.5 %. 
When administered at 10 % (0.48 mM, 0.5 ml) 15 min before nociceptive challenge, citric 
acid inhibited the nociceptive response by 96.8 %. Inhibition of the acetic acid-induced ab-
dominal constrictions was also observed when lower doses of citric acid were introduced into 
the stomach (0.2 ml of 0.1-1 %; 38.1 μmol/kg-0.38 mmol/kg). The effect was evident as early 
as 5 min after administration of citric acid into the stomach and with the maximal effect being 
at 15-30 min after dosing. Lidocaine given orally 5 min prior to citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) prevented antinociception by citric acid, but lidocaine given 15 min 
before oral introduction of citric acid enhanced the citric acid-induced inhibition of the no-
ciceptive response to acetic acid. The antinociceptive effect of orally administered citric acid 
(1 %, 48 μM; 0.38 mmol/kg, 0.2 ml) was increased by pre-treatment with propranolol 
(4 mg/kg, s. c.), yohimbine (4 mg/kg, s. c.), guanethidine (32 mg/kg, s. c.), but reduced after 
treatment with atropine (3 mg/kg, s. c.), which itself increased the nociceptive behavior. Simi-
lar inhibition of the acetic acid-induced nociceptive behavior was also observed when sodium 
citrate (pH 7.21) or 0.1 N HCl (pH 3) or 1 % sucrose solution (0.2 ml) was intragastrically 
given. It is suggested that citric acid might act to stimulate sensory afferents and that trans-
mission of nociceptive information centrally leads to the activation of descending antinocicep-
tive mechanism to a noxious stimulus. 
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INTRODUCTION 
 
Visceral abdominal pain is a common 
type of pain which is poorly understood. 
In contrast to somatic pain, the neuro-
physiologic mechanisms involved in vis-
ceral sensation are generally less well un-
derstood and the clinical management of 
visceral pain states is still limited (Joshi 
and Gebhart, 2000). Visceral pain results 
from activation of sensory afferent nerves 
innervating internal organs (Cervero and 
Laird, 1999). Viscerosensory axons are 
almost exclusively thinly myelinated  
A-delta and unmyelinated C fibers. The 
receptors exhibit chemosensitivity, ther-
mosensitivity and/or mechanosensitivity. 
The gastrointestinal tract has rich sensory 
innervation comprising intrinsic sensory 
neurons contained entirely within the gas-
trointestinal wall, intestinofugal fibres that 
project to prevertebral ganglia and vagal 
and spinal afferents that project into the 
central nervous system. Afferent fibres 
convey sensory information from the up-
per gastrointestinal tract to the CNS via 
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vagal and splanchnic nerve pathways 
(Grundy, 2002). In the gastrointestinal 
tract, sensory nerves subserve protective 
functions. Capsaicin introduced into the 
rat stomach in very low concentrations in 
μM range which stimulated the peripheral 
endings of capsaicin sensitive sensory 
nerves effectively prevented gastric mu-
cosal injury evoked by pylorus ligation, 
topical acidified aspirin or ethanol (Ab-
del-Salam et al., 1999; Szolcsányi and 
Barthó, 2001). 
An intriguing question is whether a 
nociceptive stimulus applied to the gastric 
mucosa would affect visceral nociception 
evoked for example by i. p. injection of 
acetic acid in mice, a model of inflamma-
tory visceral pain. In previous studies, 
capsaicin or piperine introduced into the 
stomach inhibited abdominal constrictions 
evoked by i. p. injection of acetic acid in 
mice. It would appear thus those nocicep-
tive stimuli. In the present study we aimed 
to investigate whether citric acid would 
evoke a similar effect. Citric acid is a 
weak organic acid found in the greatest 
amounts in citrus fruits. It is a natural pre-
servative and is also used to add an acidic 
(sour) taste to foods and soft drinks. Citric 
acid applied to the tip of the tongue in 
human subjects produced taste sensations 
and also irritation mediated via capsaicin-
sensitive fibers since reductions in irrita-
tion and taste occurred following treat-
ment with capsaicin (Gilmore and Green, 
1993). Intraoral infusions of 0.1 M citric 
acid in awake, behaving rats elicited Fos-
like immunoreactivity in the nucleus of 
the solitary tract (Travers, 2002). Citric 
acid 250 mM applied to the dorsal surface 
of the tongue in human caused irritation 
which involves acid-sensitive ion chan-
nels and vanilloid receptors (Dessirier et 
al., 2000). 
The present study was therefore de-
signed to test the effect of intragastric 
administration of citric acid on the vis-
ceral nociceptive response to intraperi-
toneal injection of dilute acetic acid in 
mice. 
 
MATERIALS AND METHODS 
 
Animals 
Swiss male albino mice 22-25 g of 
body weight were used. Standard labora-
tory food and water were provided ad libi-
tum. Experiments were performed be-
tween 9 am and 3 pm. The study was 
done in the Department of Pharmacology, 
National Research Centre, Cairo on Feb-
ruary, 2006. Animal procedures were per-
formed in accordance with the Ethics 
Committee of the National Research Cen-
tre and followed the recommendations of 
the National Institutes of Health Guide for 
Care and Use of Laboratory Animals 
(Publication No. 85-23, revised 1985). 
Equal groups of 6 mice each were used in 
all experiments.  
 
Acetic acid-induced writhing 
Separate groups of 6 mice each were 
administered vehicle (distilled water) or 
citric acid (0.01, 0.1, 1 or 10 %, 0.5 ml 
p. o.). After 1 h pretreatment interval, an 
i. p. injection of 0.6 % acetic acid was 
administered (Koster et al., 1959). The 
effect of citric acid (10 %, 0.5 ml, p. o., 
n = 6) administered 15 min before acetic 
acid was also studied. Other experiments 
were designed in an attempt to elucidate 
the dose and time-dependent effect of cit-
ric acid. The latter was given at 0.2 ml 
volume and 0.1 or 1 % concentration, 
5 min, 15 min or 1 h prior to i. p. acetic 
acid injection (n = 6/group). Each mouse 
was then placed in an individual clear 
plastic observational chamber, and the to-
tal number of writhes made by each 
mouse was counted for 30 min after acetic 
acid administration. 
Further experiments aimed to investi-
gate the mechanisms by which citric acid 
exerts its anti-nociceptive effect. Citric 
acid at concentration of 1 % and 0.2 ml 
volume, p. o. was selected to be used in 
the subsequent experiments and adminis-
tered 30 min prior to nociceptive chal-
lenge with i. p. acetic acid. Thus, the ef-
fect of the local anaesthetic lidocaine 
given 5 or 15 min prior to citric acid (1 %, 
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0.2 ml, p. o.) or vehicle was studied. Fur-
ther, the effect of the beta adrenoceptor 
antagonist, propranolol (4 mg/kg, s. c.), 
the alpha-2 adrenoceptor antagonist yo-
himbine (5 mg/kg, s. c.), the adrenergic 
blocker, guanethidine (32 mg/kg, s. c.), 
the muscarinic acetylcholine receptor an-
tagonist atropine (0.8, 1.6 or 3 mg/kg, 
s. c.) were examined on antinociception 
caused by citric acid. Antagonist drugs 
were administered 30 min before citric 
acid (1 %, 0.2 ml, p. o.) and i. p. admini-
stration of acetic acid was carried out 
30 min after citric acid was given. In addi-
tion, effect of co-administered theophyl-
line (10 or 30 mg/kg, s. c.) on the antino-
ciceptive effect of orally administered cit-
ric acid (1 %, 0.2 ml, p. o.) was studied. 
Moreover, we studied the effect of 
orally administered sodium citrate 
(pH 7.21; sodium hydroxide added to 
make pH 7.21 from pH 3.12) or 
0.1 N HCl (pH 3) or 1 % sucrose solution 
(0.2 ml) on the abdominal constrictions 
caused by i. p. injection of acetic acid. 
Test solutions were given 30 min prior to 
nociceptive challenge with acetic acid. 
 
Drugs and chemicals 
Citric acid, atropine sulfate, yo-
himbine hydrochloride, propranolol hy-
drochloride and guanethidine hydrochlo-
ride (Sigma, St. Louis, USA) were used. 
Analytical-grade glacial acetic acid 
(Sigma, St. Louis, USA) was diluted with 
pyrogen-free saline to provide a 0.6 % 
solution for i. p. injection. All drugs were 
dissolved in isotonic (0.9 % NaCl) saline 
solution immediately before use. Stock 
solutions of capsaicin (10 mg/ml) con-
tained 10 % ethanol, 10 % Tween 80, 80 % 
saline solution.  
 
Statistical analysis 
Data are expressed as mean ± S.E. 
Data were analyzed by one way analysis 
of variance, followed by a Tukey's multi-
ple range test for post hoc comparison of 
group means. When there were only two 
groups a two-tailed Student's t test was 
used. For all tests, effects with a probabil-
ity of P < .05 were considered to be sig-
nificant. 
 
RESULTS 
 
Citric acid introduced into the stom-
ach of mice at increasing concentrations 
of 0.1, 1 or 10 % (4.8 μM-0.48 mM; 
95 μmol/kg–9.5 mmol/kg, 0.5 ml) caused 
a dose-dependent inhibition of abdominal 
constrictions induced 1 h later by i. p. ace-
tic acid injection by –51 % to -69.5 %. 
The lower concentration of 0.01 % of ace-
tic acid was without effect on the nocicep-
tive response. Marked inhibition of the 
nociceptive response by 96.8 % was ob-
served when citric acid at 10 % 
(0.48 mM, 0.5 ml) was orally introduced 
15 min before nociceptive challenge 
(Fig. 1).  
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Figure 1: Inhibition of the acetic acid-induced 
abdominal constrictions in mice by citric acid 
administered orally. Citric acid was introduced 
into the stomach at concentrations of 0.01-
10 % (0.48 μM-0.48 mM; 9.5 μmol/kg– 
9.5 mmol/kg, 0.5 ml) 1 h prior to testing. The 
effect of citric acid (10 % solution, 0.5 ml) 
administered 15 min prior to acetic acid chal-
lenge is also shown (last column). Data ex-
pressed as mean ± S.E and percent inhibition 
(%) compared to the vehicle-treated group.  
* : p<0.05 vs. vehicle  
+ : p<0.05 vs. 0.1 % citric acid. 
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Lower doses of citric acid were also 
effective in inhibiting the visceral no-
ciceptive response to i. p. acetic acid. 
Thus citric acid introduced into the stom-
ach at 0.2 ml of 0.1-1 % solution (4.8 μM-
48 μM; 38.1 μmol/kg-0.38 mmol/kg), 5, 
15 or 60 min prior to nociceptive chal-
lenge reduced the number of abdominal 
constrictions by 9.4-19.5 %, 30.3–46.3 % 
and by 14.3-20.5 %, respectively (Fig. 2). 
It would thus appear that the analgesic 
effect of citric acid is both dose and time 
dependent, with the effect being evident 
as early as 5 min after administration of 
citric acid into the stomach and with the 
maximal effect being at 15-30 min after 
dosing. Accordingly in further experi-
ments, citric acid was used in a concentra-
tion of 1 % and at 30 min prior to no-
ciceptive testing. 
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Figure 2: Effect of citric acid introduced into the 
stomach at 0.2 ml and concentrations of 0.1 or 
1 % solution (4.8 μM or 48 μM; 38.1 μmol/kg or 
0.38 mmol/kg) on the acetic acid-induced ab-
dominal constrictions in mice. Citric acid was 
given 5, 15 or 60 min prior to nociceptive chal-
lenge. Data expressed as mean ± S.E and 
percent inhibition (%) compared to the vehicle-
treated group.   
* : p<0.05 vs. vehicle  
+ : p<0.05 vs. corresponding concentration of 
citric acid at 5 min or 1 h. 
 
 
Lidocaine (2 %, 0.1 ml) itself given 
orally 5 min prior to intragastric saline 
administration (0.2 ml) reduced the num-
ber of abdominal constrictions caused 
30 min later by i. p. acetic acid by 44.1 %. 
When lidocaine was given 5 min prior to 
intragastric citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) no further inhibi-
tion of the nociceptive reaction was noted. 
Meanwhile, lidocaine given 15 min before 
oral introduction of citric acid enhanced 
the citric acid-induced inhibition of the 
nociceptive response to acetic acid 
(Fig. 3).  
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Figure 3: Effect of lidocaine (2 %, 0.1 ml, 
p. o.) on antinociception induced by orally 
administered citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) in the abdominal con-
striction assay in mice. Lidocaine was admin-
istered 5 (A) or 15 min (B) prior to citric acid. 
The nociceptive challenge with i. p. acetic 
acid was carried out 30 min after citric acid 
administration.  
* : p<0.05 vs. vehicle and between different 
groups as shown in figure 
+ : p<0.05 vs. citric acid group.  
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Atropine administered at 0.8 or 
1.6 mg/kg, s. c., had no effect on the anal-
gesic action of citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) (Fig. 4). 
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Figure 4: Effect of atropine (0.8 or 1.6 mg/kg, 
s. c.) on antinociception induced by orally 
administered citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) in the abdominal con-
striction assay in mice. Atropine was adminis-
tered 30 min before citric acid (1 %, 0.2 ml, 
p. o.) and i. p. administration of acetic acid 
was carried out 30 min after citric acid was 
given. Data represent mean ± S.E and per-
cent inhibition (%) compared to the vehicle-
treated group.  
* : p<0.05 compared to vehicle and between 
different groups as shown in the figure 
+ : p<0.05 vs. citric acid group.  
 
At a higher dose of 3 mg/kg, atropine 
itself enhanced visceral pain and masked 
the antinociceptive effect of citric acid 
(Fig. 5).  
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Figure 5: Effect of atropine (3 mg/kg, s. c.) on 
antinociception induced by orally adminis-
tered citric acid (1 %, 48 μM; 0.38 mmol/kg, 
0.2 ml) in the abdominal constriction assay in 
mice. Atropine was administered 30 min be-
fore citric acid (1 %, 0.2 ml, p. o.) and i. p. 
administration of acetic acid was carried out 
30 min after citric acid was given. Data repre-
sent mean ± S.E and percent inhibition (%) 
compared to the vehicle-treated group.  
* : p<0.05 compared to vehicle and between 
different groups as shown in the figure. 
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The antinociceptive effect of orally 
administered citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) was increased by 
pre-treatment with propranolol (4 mg/kg, 
s. c.), yohimbine (4 mg/kg, s. c.), 
guanethidine (32 mg/kg, s. c.) (Fig. 6). 
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Figure 6: Effect of propranolol (4 mg/kg, 
s. c.), yohimbine (4 mg/kg, s. c.) or 
guanethidine (32 mg/kg, s. c.) on antinocicep-
tion caused by orally administered citric acid 
(1 %, 48 μM; 0.38 mmol/kg, 0.2 ml) in the ab-
dominal constriction assay in mice. Antago-
nist drugs were administered 30 min before 
citric acid (1 %, 0.2 ml, p. o.) and i. p. admini-
stration of acetic acid was carried out 30 min 
after citric acid was given. Data represent 
mean ± S.E and percent inhibition (%) com-
pared to the vehicle-treated group.  
* : p<0.05 compared to vehicle and between 
different groups as shown in the figure 
+ : p<0.05 compared to citric acid group. 
 
The antinociceptive effect of orally 
administered citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) was reduced by 
pre-treatment with theophylline at 
30 mg/kg (Fig. 7). 
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Figure 7: Effect of theophylline (10 or 
30 mg/kg, s. c.) on antinociception caused by 
orally administered citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml) in the abdominal con-
striction assay in mice. Theophylline was co-
administered with citric acid 30 min before 
i. p. injection of acetic acid. Data represent 
mean ± S.E and percent inhibition (%) com-
pared to the vehicle-treated group.  
* : p<0.05 compared to vehicle and between 
different groups as shown in the figure 
+ : p<0.05 compared to citric acid group. 
 
Inhibition of the acetic acid-induced 
nociceptive behavior was also observed 
when sodium citrate (0.2 ml, pH 7.21) or 
0.1 N HCl (0.2 ml, pH 3) (Fig. 8) or 1 % 
sucrose solution (0.2 ml) was intragastri-
cally given (Fig. 9). There was an additive 
antinociception following the administra-
tion of citric acid and sucrose solution 
(Fig. 9). 
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Figure 8: Effect of orally administered sodium 
citrate (pH 7.21) or 0.1 N HCl (pH 3) on the 
abdominal constrictions caused by i. p. injec-
tion of acetic acid. Test solutions were given 
30 min prior to nociceptive challenge with 
acetic acid.  
* : p<0.05 compared to vehicle. 
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Figure 9: Effect of orally administered 1 % 
sucrose solution (0.2 ml) on the abdominal 
constrictions caused by i. p. injection of acetic 
acid and on the antinociception caused by 
orally administered citric acid (1 %, 48 μM; 
0.38 mmol/kg, 0.2 ml). Test solutions were 
given 30 min prior to nociceptive challenge with 
acetic acid.  
* : p<0.05 compared to vehicle and between 
different groups as shown in the figure 
+ : p<0.05 compared to citric acid group. 
 
DISCUSSION 
 
The present study indicated for the 
first time that the nociceptive behavioral 
response to noxious peritoneal stimulus 
(acetic acid) decreased following intragas-
tric administration of citric acid in mice. 
Inhibition of the acetic acid-induced no-
ciceptive behavior was also observed 
when sodium citrate (pH 7.21) or 
0.1 N HCl (pH 3) or 1 % sucrose solution 
was intragastrically given. It would thus 
appear that a number of noxious and gus-
tatory stimuli interfere with processing of 
noxious visceral stimulation at a distant 
site in the gastrointestinal tract. Gustatory 
and other oral sensory signals appear to 
trigger neural reflexes. In human subjects, 
oral application of sucrose 0.07, 0.28, 
1.12 M or citric acid solutions 0.002, 
0.008, 0.032 M elicited an increase in 
heart rate within 5 sec that peaked 40 sec 
and declined in 801-100 sec after applica-
tion (Horio, 2000). In the present study, 
however, the antinociceptive effect of cit-
ric acid was not due to sympathetic or 
cholinergic reflexes. In previous studies, 
intragastric administration of capsaicin or 
piperine inhibited abdominal constrictions 
evoked by i. p. acetic acid in mice (Abdel-
Salam, 2006, Abdel-Salam et al., 2007).  
It has been shown that various no-
ciceptive intestinal stimuli, e. g. chemical 
peritoneal stimulation by hydrochloric 
acid, mechanical stimulation of the small 
and large intestines or direct electrical 
stimulation of mesenteric or splanchnic 
afferents suppress gastric motility via a 
spino-vagal reflex mechanism composed 
of spinal afferents in the sympathetic 
nerves, spinobulbar ascending pathways, 
and vagal nonadrenergic inhibitory fibers 
to the stomach (Glise and Abrahamsson, 
1980). It has been suggested that peri-
pheral sensory input, such as noxious 
stimulation, might be a mechanism by 
which descending inhibitory system is 
physiologically activated (Gear et al., 
1999). Studies also indicated that visceral 
noxious stimuli can result in inhibition of 
somatic inflammatory pain, e. g. an in-
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traperitoneal acetic acid produced long-
lasting inhibition of formalin-evoked so-
matic inflammatory pain behavior in 
mice. This effect was naloxone insensi-
tive, but blocked by the 5-hydroxytrypta-
mine type 2A/2C receptor antagonists 
(Kurihara et al., 2003). 
Sensations from the stomach are con-
veyed to the central nervous system by 
capsaicin-sensitive fibers. Sensory neu-
rons signal chemical noxae to the brain, a 
task that is not confined to spinal afferents 
because vagal afferents communicate gas-
tric acid and peripheral immune chal-
lenges to the brainstem and in this way 
elicit autonomic, endocrine, affective and 
behavioral reactions (Holzer, 2004a, b). In 
this context, noxious gastric distention 
induced the expression in the nucleus of 
the solitary tract of c-fos, a marker for ac-
tivity following noxious somatic or vis-
ceral stimulation (Traub et al., 1996). In-
creased c-fos transcription in the nucleus 
of the solitary tract and the spinal cord 
also followed intragastric capsaicin 
(3.2 mM; 2 ml) administration. The no-
ciceptive information being processed 
both by gastric vagal and intestinal spinal 
afferents (Holzer et al., 2005). Vagal af-
ferent input from the acid-threatened gas-
tric mucosa leads to the activation of sub-
cortical brain nuclei that are involved in 
emotional, behavioral, neuroendocrine, 
autonomic and antinociceptive reactions 
to a noxious stimulus (Michl et al., 2001). 
There is also evidence of a descending 
modulation of spinal visceral nociceptive 
transmission, whereby electrical and/or 
chemical (glutamate) stimulation of 
periaqueductal gray or rostral ventrome-
dial medulla (Giesler and Liebeskind, 
1976; Ness and Gebhart, 1987; Zhuo et 
al., 2002) or thalamic mucleus submedius 
(Yang and Follett, 2003) attenuated the 
neuronal responses to a noxious visceral 
stimulus (colorectal distension).  
Citric acid has sensory properties. In 
human subjects, the application of citric 
acid to the tongue elicited taste sensations 
and irritations mediated via capsaicin-
sensitive fibers since reductions in irrita-
tion and taste occurred following treat-
ment with capsaicin (Gilmore and Green, 
1993). Citric acid 250 mM applied to the 
dorsal surface of the tongue in human 
caused irritation which involves acid-
sensitive ion channels and vanilloid recep-
tor mechanism (Dessirier et al., 2000). 
Intraoral infusions of 0.1 M citric acid in 
awake, behaving rats elicited Fos-like 
immunoreactivity in regions of the nu-
cleus of the solitary tract in that receive 
input from orosensory afferents and also 
in a location that mainly receives primary 
afferent input from the vagus nerve. These 
results suggest that strong gustatory stim-
uli can influence visceral afferent systems 
(Travers, 2002).  
On the other hand, glucose or sucrose 
solutions administered orally provide ef-
fective analgesia for procedural pain in 
neonates (Stevens et al., 2004; Rogers et 
al., 2006). This analgesia with sugar solu-
tions can be decreased by opioid or 
5HT2A serotonergic receptor antagonists 
(Reboucas et al., 2005). It was also sug-
gested that glucose does not directly in-
teract with Mu opioid receptors in an in 
vitro expression system and that the pur-
ported interaction between glucose and 
the opioid system may be an indirect one, 
involving release of endogenous opioids 
(Kracke et al., 2005). Intra-oral sucrose 
activates neurons in the periaqueductal 
gray and nucleus raphe magnus, two key 
brainstem sites critically involved in de-
scending pain modulation (Anseloni et al., 
2005). The analgesic effect of sucrose in-
take depends on the concentration of su-
crose solution and on the time during 
which the solution is consumed (Segato et 
al., 2005).  
Although in the present study, that cit-
ric acid and other test solutions were ad-
ministered into the stomach through oro-
gastric tube, it is also possible that the ob-
served phenomenon represents gustatory 
activation of the afferent limb of visceral 
reflex circuits. Projections from somato-
sensory neurons throughout the oral cav-
ity, and from visceral neurons in the gut, 
intermingle with gustatory neurons in the 
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NST (Whitehead and Frank, 1983) and 
GC (Barnett et al., 1995), suggesting that 
interactions should occur between taste 
and other systems. It is also possible that 
the observed antinociceptive response to 
intragastric stimuli reflects a systemic re-
sponse to the release into the circulation 
of anti-inflammatory peptide. In this con-
text, evidence has been provided that be-
yond evoking a local inflammatory reac-
tion, antidromic electrical or orthodromic 
chemical stimulation of capsaicin-
sensitive sensory nerve fibers dorsal roots, 
or sciatic nerve elicits a systemic anti-
inflammatory effect as well. The devel-
opment of this unorthodox systemic hu-
moral response was found to be due to 
somatostatin release from sensory nerve 
terminals (Thán et al., 2000).  
In conclusion, the present study pro-
vides the first evidence that the nocicep-
tive behavioral response to noxious peri-
toneal stimulation with acetic acid in mice 
could be modulated following intragastric 
administration of citric acid. It is sug-
gested that the antinociceptive effects of 
citric acid reflects the activation of a de-
scending inhibitory pain pathway in re-
sponse to visceral noxious stimulation and 
transmission of visceral nociceptive in-
formation centrally. 
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